BioSpace News Archive

Biomarkers In Breast Cancer Drug Development

Breast cancer is the leading type of cancer in terms of number of cases and rapid increase in the number of newly diagnosed breast cancer is observed during the past few years.

March 22, 2022
·
3 min read
NEW INDEPENDENT MARKET RESEARCH SAYS 84% OF US HEALTHCARE PROFESSIONALS LIKELY TO USE ORVIGLANCE IMAGING AGENT IN TARGET POPULATION

The independently conducted survey asked 270 healthcare professionals in the US (radiologists, oncologists and nephrologists) about their choices of imaging and contrast agents in patients with cancer.

March 22, 2022
·
3 min read
Pharm Country

Hoth Therapeutics Announces it Has Successfully Completed Manufacturing Feasibility of the HT-KIT Drug Substance

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, today announced development updates for its cancer therapeutic, HT-KIT after receiving Orphan Drug Designation from the U.S. Food and Drug Administration (FDA) on March 11, 2022.

March 22, 2022
·
4 min read
Defence Therapeutics: An Anti-Cancer Solutions Platform Company Advancing Its Versatile Accum Technology

his is the final step for submission to the MHRA in preparation for its Phase I Clinical Trial against melanoma planned for Q4 of 2022.

March 22, 2022
·
4 min read
Cardiol Therapeutics to Participate in Cantor Fitzgerald’s Virtual Rare Orphan Disease Summit

Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) (“Cardiol” or the “Company”), a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory therapies...

March 22, 2022
·
3 min read
Awakn Life Sciences Announces Closing of Private Placement

Each Unit is comprised of one common share (each, a “Common Share”) in the capital of the Company and one-half of one whole Common Share purchase warrant (each whole warrant, a “Warrant”).

March 22, 2022
·
5 min read
FDA

Berkshire Sterile achieves its first commercial drug approval by the FDA

On March 1, 2022, a long-term client of Berkshire Sterile Manufacturing (BSM) announced the FDA approval of their Abbreviated New Drug Application (ANDA) for their generic apomorphine hydrochloride cartridges.

March 22, 2022
·
2 min read
Pharmaceutical Chemicals Market Size, Growth, Trends, Report 2021-2030

According to Precedence Research, the pharmaceutical chemicals market size is expected to hit US$ 197.4 billion by 2030 and expanding growth at a registered CAGR of 6.9% from 2021 to 2030.

March 22, 2022
·
5 min read
Business

Akron BioProducts and Vor Bio to Collaborate on the Development and cGMP Manufacture of Nucleases

Akron BioProducts, a leading manufacturer of cGMP-compliant technologies for cell and gene therapy, and Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced an agreement to develop and manufacture cGMP nucleases.

March 22, 2022
·
2 min read
Targeted Therapeutics Market Size, Growth, Trends, Report 2021 to 2030

The targeted therapeutics market size was reached at US$ 67 billion in 2021 and is predicted to hit US$ 109 billion by 2028 with a registered CAGR of 2.4% from 2021 to 2030.

March 22, 2022
·
4 min read